In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants

NCT01203501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1339

Last updated 2017-09-26

No results posted yet for this study

Summary

This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generic Database whose mothers were given prenatal MgSO4, data were prospectively collected on maternal/infant conditions and magnesium exposure (including indications, timing and duration of exposure).

Conditions

  • Infant, Newborn
  • Infant, Low Birth Weight
  • Infant, Small for Gestational Age
  • Infant, Premature
  • Intracranial Hemorrhages
  • Leukomalacia, Periventricular
  • Cerebral Palsy

Sponsors & Collaborators

  • National Center for Research Resources (NCRR)

    collaborator NIH
  • NICHD Neonatal Research Network

    lead NETWORK

Principal Investigators

  • James A. Lemons, MD · Indiana University

  • Waldemar A. Carlo, MD · University of Alabama at Birmingham

  • William Oh, MD · Brown University, Womens and Infants Hospital

  • Avroy A. Fanaroff, MD · Case Western Reserve University, Rainbow Babies & Children's Hospital

  • Edward F. Donovan, MD · Children's Hospital Medical Center, Cincinnati

  • Barbara J. Stoll, MD · Emory University

  • Ann R. Stark, MD · Brigham and Women's Hospital

  • Charles R. Bauer, MD · University of Miami

  • Lu-Ann Papile, MD · University of New Mexico

  • David K. Stevenson, MD · Stanford University

  • Sheldon B. Korones, MD · University of Tennessee

  • Jon E. Tyson, MD MPH · University of Texas Southwestern Medical Center

  • Seetha Shankaran, MD · Wayne State University

  • Richard A. Ehrenkranz, MD · Yale University

  • Raymond Bain, PhD · George Washington University

Eligibility

Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1996-07-31
Primary Completion
1998-06-30
Completion
2000-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01203501 on ClinicalTrials.gov